Abstract: The present invention relates to a nutritional supplement for use to ameliorate the effect of a pneumonia in a human, which supplement comprises a mixture of bioflavonoids which contains at least 45% wt/wt (of the total bioflavonoids) of naringin and at least 15% wt/wt of neohesperidin, wherein said supplement is in a form suitable for oral administration or administration to the lung by insufflation or inhalation. The present invention also provides a method of treatment of pneumonia using the aforementioned nutritional supplements.
Abstract: The present invention relates to a nutritional supplement for use by oral administration to a human for ameliorating adverse medical conditions deriving at least in part from a metabolic dysfunction and/or an intestinal dysfunction, which supplement is in a form suitable for oral administration and comprises a mixture of bioflavonoids which include at least 45% wt/wt naringin and at least 15% wt/wt of neohesperidin of the bioflavonoids present. The present invention also provides a method of treatment of the aforementioned medical conditions using the aforementioned nutritional supplements.
Abstract: The present invention relates to pharmaceutical compositions and their use for preventing, eradicating or ameliorating infections. More particularly, the compositions comprise one or more flavonoids, such as naringin and neohesperidin and caprylic acid and/or polylysine. Such compositions can, for example, be employed for reducing or eliminating bacteria, fungi and other parasites from water, such as water intended for drinking or from food.
Abstract: Polymeric materials are described which have a bioflavonoid coating, the bioflavonoid content of the coating comprising at least naringin and neohesperidin. The use of such coated polymeric materials is also described as well as the process for making the coated polymeric materials.
Type:
Grant
Filed:
October 2, 2020
Date of Patent:
February 14, 2023
Assignee:
Citrox Biosciences Limited
Inventors:
Howard Thomas, Denis Dowling, Marie G. Katsikogianni
Abstract: The present invention relates to pharmaceutical compositions and their use for preventing, eradicating or ameliorating infections. More particularly, the compositions comprise one or more flavonoids, such as naringin and neohesperidin and caprylic acid and/or polylysine. Such compositions can, for example, be employed for reducing or eliminating bacteria, fungi and other parasites from water, such as water intended for drinking or from food.
Abstract: Polymeric materials are described which have a bioflavonoid coating, the bioflavonoid content of the coating comprising at least naringin and neohesperidin. The use of such coated polymeric materials is also described as well as the process for making the coated polymeric materials.
Type:
Grant
Filed:
January 26, 2018
Date of Patent:
October 6, 2020
Assignee:
CITROX BIOSCIENCES LIMITED
Inventors:
Howard Thomas, Denis Dowling, Marie G. Katsikogianni
Abstract: There is described a method of sterilizing surfaces using flavonoids, for example mixtures containing inter alia naringin and neohesperidin, by misting.
Abstract: Polymeric materials are described which have a bioflavonoid coating, the bioflavonoid content of the coating comprising at least naringin and neohesperidin. The use of such coated polymeric materials is also described as well as the process for making the coated polymeric materials.
Type:
Grant
Filed:
August 22, 2013
Date of Patent:
January 30, 2018
Assignee:
CITROX BIOSCIENCES LIMITED
Inventors:
Howard Thomas, Denis Dowling, Marie G. Katsikogianni
Abstract: There is described a method of sterilizing surfaces using flavonoids, for example mixtures containing inter alia naringin and neohesperidin, by misting.